[HTML][HTML] microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
Nature communications, 2017•nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent genetic cause
of renal failure. Here we identify miR-17 as a target for the treatment of ADPKD. We report
that miR-17 is induced in kidney cysts of mouse and human ADPKD. Genetic deletion of the
miR-17∼ 92 cluster inhibits cyst proliferation and PKD progression in four orthologous,
including two long-lived, mouse models of ADPKD. Anti-miR-17 treatment attenuates cyst
growth in short-term and long-term PKD mouse models. miR-17 inhibition also suppresses …
of renal failure. Here we identify miR-17 as a target for the treatment of ADPKD. We report
that miR-17 is induced in kidney cysts of mouse and human ADPKD. Genetic deletion of the
miR-17∼ 92 cluster inhibits cyst proliferation and PKD progression in four orthologous,
including two long-lived, mouse models of ADPKD. Anti-miR-17 treatment attenuates cyst
growth in short-term and long-term PKD mouse models. miR-17 inhibition also suppresses …
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent genetic cause of renal failure. Here we identify miR-17 as a target for the treatment of ADPKD. We report that miR-17 is induced in kidney cysts of mouse and human ADPKD. Genetic deletion of the miR-17∼ 92 cluster inhibits cyst proliferation and PKD progression in four orthologous, including two long-lived, mouse models of ADPKD. Anti-miR-17 treatment attenuates cyst growth in short-term and long-term PKD mouse models. miR-17 inhibition also suppresses proliferation and cyst growth of primary ADPKD cysts cultures derived from multiple human donors. Mechanistically, c-Myc upregulates miR-17∼ 92 in cystic kidneys, which in turn aggravates cyst growth by inhibiting oxidative phosphorylation and stimulating proliferation through direct repression of Pparα. Thus, miR-17 family is a promising drug target for ADPKD, and miR-17-mediated inhibition of mitochondrial metabolism represents a potential new mechanism for ADPKD progression.
nature.com